Loading blog posts...
August 22, 2026 • 3 min read
When you think of modern orthodontics, Align Technology (ALGN) is likely the first name that comes to mind. As the powerhouse behind Invisalign clear aligners and iTero intraoral scanners, they have dramatically changed how patients and doctors approach teeth straightening. But how is the business actually performing in a shifting macroeconomic climate? We want to dig into the income statement from the company to see how things are going and what we can learn from it.
Let's unpack the numbers from their latest 10-Q filing for the second quarter of 2026 to see what's driving their financials.
Align's business is split into two primary segments: Clear Aligners (the Invisalign treatments themselves) and Systems and Services (iTero scanners and CAD/CAM software used by dental professionals to scan and model teeth).
In Q2 2026, the company posted total revenues of $1.06 billion, a respectable 4.3% increase year-over-year. The heavy lifting was done entirely by the Clear Aligner segment, which brought in $870.9 million, an 8.2% jump from Q2 2025. This growth is backed by strong underlying demand, with total case volume rising 7.4% to nearly 692,000 shipments. Notably, volume for teens and growing patients—a critical demographic for long-term market penetration—grew by 7.2%.
Conversely, the Systems and Services division faced headwinds. Revenue in this segment dropped 10.8% year-over-year to $185.3 million. This suggests that while patients are still actively seeking out aligners, dental practices might be tightening their capital expenditure budgets and holding off on upgrading their expensive imaging hardware.
Align remains a highly profitable enterprise with excellent unit economics. Total gross profit for the quarter landed at $757.4 million, yielding a robust gross margin of 71.7%.
However, looking at the bottom line reveals a dip. Net income for Q2 2026 was $108.3 million (or $1.51 per diluted share), down from $124.6 million ($1.72 per share) in the same period last year. Why the drop despite higher revenues? A significant culprit was a $38.7 million charge for "Legal settlements and contingencies"—an expense line that was completely zero in Q2 2025. Align has historically fiercely defended its intellectual property and faced various antitrust and patent disputes. This quarter, those legal battles took a noticeable bite out of operating income, which settled at $154 million (a 14.6% margin).
Beyond the core operations, the income statement also highlights a $7 million fair value adjustment gain related to Align's equity investments in privately held companies. A major piece of this is Align's strategic, multi-million dollar investment in Heartland Dental, one of the largest Dental Support Organizations (DSOs) in the United States. By investing directly in a massive network of multi-disciplinary dental practices, Align tightens its relationship with the providers who ultimately prescribe its products, a move that provides both financial upside and structural market alignment.
Align Technology continues to dominate the clear aligner market, successfully growing its core product volumes even as doctors delay imaging hardware purchases. Moving forward, the company will need to navigate global macroeconomic pressures and competition from ambitious rivals like Straumann and Angelalign. But with $1.1 billion in cash on hand and a highly profitable core business, Align seems well-positioned to keep its momentum going.
Last updated: August 22, 2026
Explore prior quarterly filings, historical revenue breakdowns, and earnings trends.
